ENSG The Ensign Group, Inc.
Healthcare$171.43+0.00%OpenMarket Cap: $10.02B
As of 2026-05-26
Valuation
P/E (TTM)
33.62
PEG
2.18
P/B
4.20
P/S
1.91
EV/EBITDA
19.77
DCF Value
$102.88
FCF Yield
4.0%
Div Yield
0.1%
Margins & Returns
Gross Margin
13.9%
Operating Margin
8.5%
Net Margin
6.9%
ROE
16.6%
ROA
6.5%
ROIC
7.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.39B | 16.4% | $124.9M | $99.7M | $— | $0.13 |
| Q4 null | $1.36B | 8.7% | $123.8M | $95.5M | $— | $0.13 |
| FY null | $5.06B | 15.8% | $425.3M | $344.0M | $— | $0.32 |
| Q3 null | $1.30B | 14.7% | $96.2M | $83.8M | $— | $0.13 |
| Q2 null | $1.23B | 16.2% | $103.9M | $84.4M | $— | $0.13 |
| Q1 null | $1.17B | 16.0% | $101.4M | $80.3M | $— | $0.13 |
| Q4 null | $1.13B | 15.8% | $100.8M | $79.7M | $— | $0.12 |
| FY null | $4.26B | 15.7% | $358.3M | $298.0M | $— | $0.30 |
| Q3 null | $1.08B | 15.4% | $89.3M | $78.4M | $— | $0.12 |
| Q2 null | $1.04B | 15.7% | $86.0M | $71.0M | $— | $0.12 |
| Q1 null | $1.01B | 15.7% | $82.2M | $68.8M | $— | $0.12 |
| Q4 2023 | $980.4M | 15.2% | $22.8M | $21.7M | $0.38 | $0.12 |